| |
NewswireToday - /newswire/ -
Boston, MA, United States, 2019/09/06 - According to a new market research report launched by Inkwood Research, The Global Diabetes Drugs Market was valued at nearly $34,296 million in 2018 and is anticipated to reach around $60,435 million by 2027, growing at a CAGR of 6.50%, 2019-2027.
|
| |
Browse 33 market data Tables and 22 Figures spread over 190 Pages along with in-depth analysis on Global Diabetes Drugs Market by Diabetes Type (Type 1, Type 2), by Product Class (Insulin (Fast acting insulin, Intermediate-acting insulin, Long-acting insulin), Non-insulin (DPP-4 inhibitor, GLP-1 receptors agonists, SGLT-2 inhibitors, Other non-insulin drugs)), & by Geography.
This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects of this comprehensive market, by assessing major geographies, and is a valuable asset for the existing players, new entrants, and future investors. The study presents a detailed market analysis, with inputs derived from industry professionals across the value chain.
Global Diabetes Drugs Market scenario
The increase in the prevalence of diabetes, advances in insulin delivery technology, and the growing elderly population are primarily driving the growth of the Global Diabetes Drugs market.
The Global Diabetes Drugs Market report provides data tables and includes charts and graphs for visual analysis.
Request Free Sample Report for Global Diabetes Drugs Market by diabetes type, product class, and Geography.
Market Segmentation
On the basis of Diabetes Type, Global Diabetes Drugs market is segmented into:
• Type 1
• Type 2
On the basis of Product Class, Global Diabetes Drugs market is segmented into:
• Insulin
oFast acting insulin
oIntermediate-acting insulin
oLong-acting insulin
• Non-insulin
oDPP-4 inhibitor
oGLP-1 receptors agonists
oSGLT-2 inhibitors
oOther non-insulin drugs
Report Highlights
- The report provides a detailed analysis of the current and future market trends, to identify the investment opportunities
- Market forecasts till 2027, using estimated market values as the base numbers
- Key market trends across the business segments, regions and countries
- Key developments and strategies observed in the market
- Market dynamics such as drivers, restraints, opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2027
• ASTRAZENECA
• BRAUN MELSUNGEN AG
• NOVO NORDISK A/S
• SANOFI
• DIAVACS INC.
• XOMA CORP.
• ALBIREO PHARMA INC.
• MACROGENICS, INC.
• ASTELLAS PHARMA
• GLAXOSMITHKLINE
• MERCK
• PFIZER
• XERIS PHARMACEUTICALS
Related Reports
Global Antithrombotic Drugs market - Global Antithrombotic Drugs market is predicted to exhibit a CAGR of 6.79% by revenue during the forecast years 2019-2027.
Global Opioids Drug market - Global Opioids Drug market is predicted to exhibit a CAGR of 2.52% by revenue during the forecast years 2019-2027.
Global Hyperphosphatemia Drug market The Global Hyperphosphatemia Drug market is predicted to exhibit a CAGR of 16.13% during the forecast years 2019-2027.
About Inkwood Research
Inkwood Research (inkwoodresearch.com) is a leading market & industry research firm offers you consulting services, syndicated & customized market research reports, business analysis & more.
|
sales[.]inkwoodresearch.com 
